Assessment of the Improvement in Cognitive Levels of Postmenopausal Depression Patients by Estrogen
Conditions: Postmenopausal Depression; Estrogen Interventions: Drug: Fematon (estradiol/estradiol-norethindrone acetate combination tablet package)+SSRIs; Drug: SSRIs Sponsors: Xiao Wang Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
MYFEMBREE ®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination Therapy
Conditions: Pregnancy Related; Pregnancy Complications; Pregnancy, High Risk Intervention: Drug: Relugolix + Estradiol + Norethindrone Acetate Sponsor: Myovant Sciences GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2023 Category: Research Source Type: clinical trials
Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Conditions: Uterine Leiomyoma; Uterine Fibroids Interventions: Drug: Relugolix; Drug: Estradiol/norethindrone acetate; Drug: Placebo for relugolix; Drug: Placebo for E2/NETA Sponsor: Myovant Sciences GmbH Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2018 Category: Research Source Type: clinical trials
